You are on page 1of 147

Annual Product Review (APR)

(F.Y. 78/79)
Product Name: Vaslod-2.5 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)% Assay


Average Thickness Diameter
Batch No: (Amlodipine
Sifting Mixing Lubrication Wt. (mg) Min Max (mm) (mm) Min Max Besylate)
8001 35 20 10 103.8 103.90% 110.70% 3 6.39 108.60% 116.50% 108.10%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Vaslod-5 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)% Assay


Average Thickness Diameter
Batch No: (Amlodipine
Sifting Mixing Lubrication Wt. (mg) Min Max (mm) (mm) Min Max Besylate)
8010 30 30 10 103.5 96.10% 106.20% 2.98 6.43 101.90% 110.70% 103.90%
8011 40 30 10 101.9 98.10% 102.30% 2.98 6.41 102.30% 106.50% 103.80%

Manufacturing Time
45
40
40
35
30 30 30
30
25
Min

20
15
10 10
10
5
0
Sifting Mixing Lubrication
8010 8011
Average Wt.
104
103.5
103.5

103

102.5
mg

102 101.9

101.5

101
1 2

Uniformity of Content
108.00%
106.20%
106.00%
104.00%
102.30%
102.00%
100.00%
98.10%
(%)

98.00%
96.10%
96.00%
94.00%
92.00%
90.00%
Min Max
8010 8011
98.00%

(
96.10%
96.00%
94.00%
92.00%
90.00%
Min Max
8010 8011

Thickness
3.5
2.98 2.98
3

2.5

2
mm

1.5

0.5

0
1 2

Diameter
6.435
6.43
6.43

6.425

6.42
mm

6.415
6.41
6.41

6.405

6.4
1 2
m
6.415
6.41
6.41

6.405

6.4
1 2

Dissolution (D)
112.00% 110.70%
110.00%
108.00%
(%)

106.50%
106.00%
104.00%
101.90% 102.30%
102.00%
100.00%
98.00%
96.00%
Min Max
8010 8011

Assay
103.92%
103.90%
103.90%
103.88%
103.86%
103.84%
(%)

103.82%
103.80%
103.80%
103.78%
103.76%
103.74%
1 2
103.86%
103.84%

(%)
103.82%
103.80%
103.80%
103.78%
103.76%
103.74%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Vaslod-10 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)% Assay


Average Thickness Diameter
Batch No: (Amlodipine
Sifting Mixing Lubrication Wt. (mg) Min Max (mm) (mm) Min Max Besylate)
8016 130 30 10 105.4 97.10% 103.50% 2.99 6.41 105.70% 112.10% 106.30%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Vaslod-AT Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution % (D) Assay

Sifting &
Batch Sifting of Preparation Mixing of Average Wt. Thickness Diameter
mixing of Amlodipine Besilate Atenolol
No: Atenolol of Atenolol & (mg) (mm) (mm) Amlodipine
Mixing Granulation Amlodipine Lubrication Min Max Atenolol
with Granulating Amlodipine Besilate
with
excepients solution Besilate
excepints
Min Max Min Max
8002 30 30 50 10 35 30 10 305.6 94.9 104.3 4.25 9.08 97.00% 101.3% 100.6% 103.8% 105.40% 106.70%
8044 55 20 60 30 30 20 10 308.9 97.5 104.7 4.19 9.06 89.40% 92.9% 109.4% 110.3% 106.10% 105.20%
8100 140 20 30 5 60 15 5 302.7 95.6 104.1 4.23 9.06 89.80% 120.9% 74.9% 101.4% 97.70% 103.50%

Manufacturing Time
160 140
120
80 55 50 60 60
30 30 20 20 30 30 35 30 30 20
40 10 15 10 10 5
5
0
g n n s n
en
ts in tio io nt ate tio
pi ix u lat pi sil ica
M ol nu ce Be
ce br
(min)

s ex
ex g ra ne Lu
in G ith pi
ith lat w di
l w nu in
e lo
lo ra ip m
o G d A
ten n
of m
lo l &
A lo
of tio A o
ng ra of ten
fti pa in
g A
Si P re ix of
m g
& in
g ix
in M
S ift
8002 8044 8100

Average Wt.
310
308.9

308

306 305.6

304
302.7

302

300

298
1 2 3
Uniformity of Content
106
104.3 104.7
104.1
104

102

100

98 97.5

96 95.6
94.9
94

92

90
1 2 3
min max

Thickness
4.26
4.25
4.25

4.24
4.23
4.23

4.22
(mm)

4.21

4.2
4.19
4.19

4.18

4.17

4.16
1 2 3

Diameter
9.085

9.08
9.08
(mm)

9.075

9.07

9.065

9.06 9.06
9.06

9.055

9.05
1 2 3
Diameter
9.085

9.08
9.08

(mm)
9.075

9.07

9.065

9.06 9.06
9.06

9.055

9.05
1 2 3

Dissolution (D)
140.00%
120.9% 103.8% 101.4%
120.00% 89.40%
109.4% 110.3%
97.00% 101.3% 100.6%
100.00% 89.80% 92.9%
74.9%
80.00%

60.00%

40.00%

20.00%

0.00%
Max
Atenolol Min
Max
Amlodipine Besilate Min
8002 8044 8100

Assay
108.00% 106.70%
106.10%
106.00% 105.40% 105.20%

104.00% 103.50%

102.00%

100.00%
97.70%
98.00%

96.00%

94.00%

92.00%
1 2 3

Amlodipine Losartan Potassium


Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Vaslod L Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution % (D) Assay


Amlodipine Losartan Potassium
Sifting of Sifting & Mixing of
Batch Losartan Preparation Sifting of mixing of Losartan Average Thickness Diameter
No: Losartan
potassium Mixing of binder Granulation Drying dried Amlodipine Potassium & Lubrication Wt. (mg) Min Max (mm) (mm) Amlodipine
Min Max Min Max Potassium
with solution granules with Amlodipine
excepients excepints Besylate

8019 30 30 50 20 30 30 30 30 10 218.6 98.2 105 4.12 8.26 94.20% 97.1% 99.6% 105.90% 102.20% 103.00%
8047 50 25 60 15 390 30 60 30 10 216.3 97.5 101.3 4.09 8.26 89.70% 92.80% 103.80% 107.40% 104.50% 103.90%
8119 150 30 30 10 60 80 30 20 10 221.3 97.6 102.8 4.1 8.29 75.40% 88.70% 100.10% 103.60% 97.70% 103.80%

Manufacturing Time
390
400
300
200 150
50 60 30 60 80 60
100 30 50 30 25 30 20 15 10 30 30 30 30 30 30 30 20 10 10 10
0
en
ts
xi
ng tio
n
io
n
in
g les nt
s
lat
e
tio
n
pi i u lat ry nu pi sy ica
M ol nu D ra ce br
ce rs ra g ex Be
ex de G ied ith ne Lu
ith in dr w pi
w fb of ne di
m o pi lo
iu tio
n ng di m
tas
s
ra fti lo A
pa Si m &
po re A m
rta
n P of s iu
sa in
g tas
Lo ix Po
of m tan
g & ar
tin ng os
Si
f fti fL
Si o
g
in
ix
8019 8047 8119
M

Average Wt.
222
221.3
221

220

219 218.6

218

217
216.3
216

215

214

213
1 2 3
Uniformity of Content
106 105

104
102.8

102 101.3

100
98.2
98 97.5 97.6

96

94

92
1 2 3
Min Max

Thickness
4.125
4.12
4.12

4.115

4.11

4.105
4.1
4.1

4.095
4.09
4.09

4.085

4.08

4.075

4.07
1 2 3

Diameter
8.295
8.29
8.29

8.285

8.28

8.275

8.27

8.265
8.26 8.26
8.26

8.255

8.25

8.245
1 2 3
8.27

8.265
8.26 8.26
8.26

8.255

8.25

8.245
1 2 3

Dissolution
120.00%
107.40%
105.90%
103.80% 103.60%
97.1% 99.6% 100.10%
100.00% 94.20% 92.80%
89.70% 88.70%

80.00% 75.40%

60.00%

40.00%

20.00%

0.00%
Max
Losartan Potassium Min
Max
Amlodipine Min
8019 8047 8119

Assay
106.00%
104.50%
103.90% 103.80%
104.00%
103.00%
102.20%
102.00%

100.00%

98.00% 97.70%

96.00%

94.00%
1 2 3

Amlodipine Losartan Potassium


Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Lulirex Cream (30g)

Mixing time(min)
Before After Assay
Batch No: pH Avg.wt. (g)
addition of addition of (Luliconzole)
API API
8003 95 145 6.4 30.07 108.50%
8030 60 150 6.18 30.44 107.50%
8031 55 170 6.15 30.05 107.10%

Mixing time
180 170
160 150
145
140
120
100 95
Min

80
60 55
60
40
20
0
1 2 3

pH
6.45
6.4
6.4
6.35
6.3
6.25
6.2 6.18
6.15
6.15
6.1
6.05
6
1 2 3
6.1
6.05
6
1 2 3

Avg.wt.
30.5
30.44
30.4

30.3

30.2

30.1 30.07
30.05

30

29.9

29.8
1 2 3

Assay
109.00%

108.50%
108.50%

108.00%

107.50%
107.50%
107.10%
107.00%

106.50%

106.00%
1 2 3
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Lulirex Cream (15g)

Mixing time(min)
Before After Avg.wt. Assay
Batch No: pH
addition of addition of (g) (Luliconazole)
API API
8033 45 140 6.12 15.10 106.60%
Annual Product Review (APR)
(F.Y.78/79)
Product Name: Dimeli-1 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)%


Average Friability Hardness Thickness Diameter Assay
Batch No: DT
Sifting Mixing Lubrication Wt. (mg) (%w/w) Min Max (kg/cm2) (mm) (mm) Min Max (Glimepiride)

8004 35 20 20 101.1 4 min 32 sec 0.13 104.90% 114.10% 3 2.94 6.42 88% 91.20% 105.20%
Annual Product Review (APR)
(F.Y.78/79)
Product Name: Dimeli-2 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)%


Average Friability Hardness Thickness Diameter Assay
Batch No: DT
Sifting Mixing Lubrication Wt. (mg) (%w/w) Min Max (kg/cm2) (mm) (mm) Min Max (Glimepiride)

8009 60 30 10 126 4 min 35 sec 0.08 107.10% 110.40% 4 3.47 6.37 82% 91.50% 105.20%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Zoom-200 Suspension (30ml)

Mixing time (min)


Avg. fill Weight
Before After Assay
Batch No: pH volume per ml
addition of addition of (Azithromycin)
(ml) (g)
API API
8006 210 190 10.86 30.15 1.11 108.20%
8015 260 205 10.32 31.3 1.1 107.50%
8032 210 180 10.6 30.3 1.11 107.90%
8043 135 355 10.49 30.5 1.11 108.50%
8106 355 130 9.26 31.8 1.1 104.70%

Mixing time
400
355 355
350
300
(min)

260
250
210 205 210
190 180
200
150 135 130

100
50
0
1 2 3 4 5

Before addition of API After addition of API

pH
11.5

11 10.86
10.6
10.49
10.5 10.32

10

9.5 9.26

8.5

8
1 2 3 4 5
8.5

8
1 2 3 4 5

Avg. fill volume


32 31.8

31.5 31.3

31

30.5
30.5
(ml)

30.3
30.15
30

29.5

29
1 2 3 4 5

Weight per ml
1.112
1.11 1.11 1.11
1.11
1.108
1.106
1.104
1.102
1.1 1.1
1.1
1.098
1.096
1.094
1 2 3 4 5

Assay
109.00% 108.50%
108.20%
107.90%
108.00% 107.50%

107.00%

106.00%

105.00% 104.70%

104.00%

103.00%

102.00%
1 2 3 4 5
105.00% 104.70%

104.00%

103.00%

102.00%
1 2 3 4 5
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Lincin Gel (15g)

Mixing time(min)
Assay
Before After Avg.wt.
Batch No: pH (Clindamycin
addition of addition of (g)
Phosphate)
API API
8012 240 165 5.5 15.03 104.70%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Lincin-A gel (15g)

Mixing time(min) Assay


Before After Avg.wt.
Batch No: pH Clindamycin
addition of addition of (g) Adapalene
Phosphate
API API
8072 200 90 5.94 15.21 106.40% 105.20%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acocin Ointment (15g)

Mixing time(min)
Before After Avg.wt. Assay
Batch No: pH
addition of addition of (g) (Mupirocin)
API API
8013 360 95 4.28 15.11 100.80%
8014 180 225 4.26 15.07 100.60%
8075 170 150 4.3 15.23 98.80%
8076 245 165 4.36 15.15 105.40%
8097 360 130 4.19 15.05 107.50%
8118 210 65 4.03 15.01 105.80%

Mixing Time
400
360 360
350
300
245
250 225
(min)

210
200 180 170 165
150
150 130
95
100 65
50
0
1 2 3 4 5 6

Before addition of API After addition of API

pH
4.4 4.36
4.3
4.3 4.28
4.26

4.19
4.2

4.1
4.03
4

3.9

3.8
1 2 3 4 5 6
3.9

3.8
1 2 3 4 5 6

Avg.wt.
15.25 15.23

15.2
15.15
15.15
15.11
15.1 15.07
15.05
15.05
15.01
15

14.95

14.9

14.85
1 2 3 4 5 6

Assay
110.00%

108.00% 107.50%

105.40% 105.80%
106.00%

104.00%

102.00% 100.80% 100.60%


100.00% 98.80%
98.00%

96.00%

94.00%
1 2 3 4 5 6
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acocin Ointment (5g)

Mixing time(min)
Batch Before After Avg.wt. Assay
pH
No: addition of addition of (g) (Mupirocin)
API API
8095 290 130 4.25 5.023 102.20%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Fevmol Suspension (60ml)

Mixing time (min)


Avg. fill
Before After Weight Assay
Batch No: pH volume
addition of addition of per ml (g) (Paracetamol)
(ml)
API API
8017 315 150 4.99 60.5 1.16 101.30%
8018 330 165 4.9 60.5 1.16 98.50%
8039 180 75 5.8 60.5 1.19 97.40%
8071 465 265 5.86 62.3 1.19 99.60%
8080 240 90 5.56 60.5 1.03 107.50%
8115 300 120 5.8 60.6 1.19 101.00%

Mixing Time
500 465
450
400
350 315 330
300
300 265
240
(min)

250
200 165 180
150
150 120
75 90
100
50
0
1 2 3 4 5 6

Before addition of API After addition of API

pH
6
5.86
5.8 5.8
5.8

5.6 5.56

5.4

5.2
4.99
5 4.9
4.8

4.6

4.4
1 2 3 4 5 6
4.8

4.6

4.4
1 2 3 4 5 6

Avg. fill volume


62.5 62.3

62

61.5

61
(ml)

60.6
60.5 60.5 60.5 60.5
60.5

60

59.5
1 2 3 4 5 6

Weight per ml
1.25

1.2 1.19 1.19 1.19


1.16 1.16
1.15

1.1

1.05 1.03

0.95
1 2 3 4 5 6

Assay
110.00%
108.00% 107.50%

106.00%
104.00%
102.00% 101.30% 101.00%
99.60%
100.00%
98.50%
98.00% 97.40%

96.00%
94.00%
92.00%
1 2 3 4 5 6
98.50%
98.00% 97.40%

96.00%
94.00%
92.00%
1 2 3 4 5 6
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Fevmol Plus Suspension (60ml)

Mixing time (min) Assay


Avg. fill Weight
Batch No: Before After pH volume per ml
addition of addition of (ml) (g) Paracetamol Ibuprofen
API API
8057 215 210 5.91 61 1.13 103.70% 102.80%
8077 305 150 5.83 61.8 1.13 98.80% 103.20%
8078 310 120 5.82 60.5 1.13 102.90% 100.10%
8079 330 150 5.78 61.7 1.12 99.70% 103.40%
8096 420 120 5.79 60.5 1.11 102.30% 104.60%
8116 360 140 5.85 60.4 1.13 102% 98.40%
8120 440 130 5.67 60.9 1.12 101.70% 98.50%

MIxing time
500
440
450 420
400 360
350 330
305 310
300
250 215 210
200
150 150 140
150 120 120 130
100
50
0
1 2 3 4 5 6 7

Before addition of API After addition of API

pH
5.95
5.91
5.9
5.85
5.85 5.83 5.82
5.78 5.79
5.8
5.75
5.7 5.67
5.65
5.6
5.55
5.5
1 2 3 4 5 6 7
Avg. fill volume
62 61.8
61.7

61.5

61
61 60.9

60.5 60.5
60.5 60.4

60

59.5
1 2 3 4 5 6 7

Weight per ml
1.135
1.13 1.13 1.13 1.13
1.13

1.125
1.12 1.12
1.12

1.115
1.11
1.11

1.105

1.1
1 2 3 4 5 6 7

Assay
106.00%
104.60%
103.70% 103.40%
104.00% 103.20% 102.90%
102.80%
102.30% 102% 101.70%
102.00%
100.10%
99.70%
100.00%
98.80% 98.40% 98.50%
98.00%

96.00%

94.00%
1 2 3 4 5 6 7

Paracetamol Ibuprofen
96.00%

94.00%
1 2 3 4 5 6 7

Paracetamol Ibuprofen
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Metfix-500 Tablets

Manufacturing Time (min)


Preparation Average Thickness Diameter Hardness
Batch No: of
Milling Sifting Granulation Drying Lubrication Wt. (mg) (mm) (mm) (Kg/cm2)
Granulating
solution
8037 140 85 120 20 100 20 600.6 4.06 12.8 6.4
8040 120 105 50 20 80 20 599.2 4.06 12.8 7.3
8102 150 115 50 70 60 20 605.1 4.19 12.8 11.2

Manufacturing Time
160 140 150
120 120
120 105115 100
85 80
70 60
80 50 50
40 20 20 20 20 20
0
in
g ng tio
n
io
n
in
g
tio
n
ill fti lat ry
M Si s o lu
n u D rica
g ra b
in G Lu
lat
anu
r
G
of
n
tio
ara
ep
Pr
8037 8040 8102

Average wt.
606
605.1
605
604
603
602
601 600.6
600 599.2
599
598
597
596
1 2 3

Thickness
4.25

4.2

4.15

4.1

4.05

3.95
1 2 3
4.05

3.95
1 2 3

Diameter
14
12.8 12.8 12.8

12

10

0
1 2 3

Hardness
12
11.2

10

8 7.3
6.4
6

0
1 2 3

Friability
0.35 0.33

0.3

0.25 0.23
0.21
0.2

0.15

0.1

0.05

0
1 2 3
0.15

0.1

0.05

0
1 2 3

Dissolution
140.00%
124.10%
120.00% 115.20%
103.40% 104.30% 105.80%
99.90%
100.00%

80.00%

60.00%

40.00%

20.00%

0.00%
1 2 3
Min Max

Assay
102.00%
101.50%

101.00%

100.10%
100.00%

99.00%
98.40%

98.00%

97.00%

96.00%
1 2 3
Dissolution (D)%
Assay
Friability
(Metformin
(% w/w) Min Max HCL)

0.21 103.40% 124.10% 98.40%


0.23 104.30% 115.20% 101.50%
0.33 99.90% 105.80% 100.10%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Metfix-850 Tablets

Manufacturing Time (min) Dissolution (D)%


Preparation Assay
Batch Average Thickness Length Hardness Friability
of (Metformin
No: Milling Sifting Granulation Drying Lubrication Wt. (mg) (mm) (mm) (Kg/cm2) (% w/w) Min Max
Granulating HCL)
solution
8038 290 385 90 30 300 20 1029.2 5.85 20.52 16 0.11 97.80% 100.30% 98.50%
8041 155 120 60 30 330 20 1028.4 5.84 20.45 15.4 0.12 98.70% 102.10% 99.30%

Manufacturing Time
450
400 385
350 330
290 300
300
250
200 155
150 120
90
100
Min

60
50 30 30 20 20
0

8038 8041

Average Wt.
1029.4
1029.2
1029.2

1029

1028.8
mg

1028.6
1028.4
1028.4

1028.2

1028
1 2
1028.4
1028.4

1028.2

1028
1 2

Thickness

5.852
5.85
5.85

5.848

5.846
(mm)

5.844

5.842
5.84
5.84

5.838

5.836

5.834
1 2

Length
20.54

20.52
20.52

20.5

20.48
mm

20.46
20.45

20.44

20.42

20.4
1 2
Hardness
16.1
16
16

15.9

15.8

15.7
(Kg/cm2)

15.6

15.5
15.4
15.4

15.3

15.2

15.1
1 2

Friability
0.122
0.12
0.12

0.118

0.116

0.114
(% w/w)

0.112
0.11
0.11

0.108

0.106

0.104
1 2
0.11

0.108

0.106

0.104
1 2

Dissolution
103.00%
102.10%
102.00%

101.00%
100.30%
100.00%

98.70%
(D)%

99.00%

98.00% 97.80%

97.00%

96.00%

95.00%
Min Max

8038 8041

Assay

99.40%
99.30%

99.20%

99.00%

98.80%

98.60%
98.50%

98.40%

98.20%

98.00%
1 2
98.80%

98.60%
98.50%

98.40%

98.20%

98.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Telsan-20 Tablets

Manufacturing Time (min) Dissolution (D)%

Batch Sifting of Average Thickness Diameter Hardness Friability Assay


Preparation Semi DT
No: Sifting Granulation dried Drying Lubrication Wt. (mg) (mm) (mm) (Kg/cm2) (%w/w) Min Max (Telmisartan)
of Active Drying
granules

8023 30 40 10 30 30 10 15 201.8 6 min 56 sec 3.66 8.23 8 0.007 98.60% 101.80% 106.10%

s
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Telsan-40 Tablets

Manufacturing Time (min) Dissolution (D)%


Batch Sifting of Average Thickness Length Hardness Friability Assay
Preparation Semi DT
No: Sifting Granulation dried Drying Lubrication Wt. (mg) (mm) (mm) (Kg/cm2) (%w/w) Min Max (Telmisartan)
of Active Drying
granules
8024 30 45 20 20 30 20 20 501.9 4 min 10 sec 4.4 16.04 12.1 0.08 102.30% 105.30% 105.30%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Atosta-10 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)%


Average Thickness Diameter Assay
Batch No:
Sifting Mixing Lubrication Wt. (mg) Min Max (mm) (mm) Min Max (Atorvastatin)

8025 65 20 20 100.4 96.80% 109.90% 3 6.69 90.10% 97.60% 108.70%


8026 85 30 10 100.2 84.10% 104.10% 2.92 6.61 92.80% 97.90% 109.70%

Manufacturing Time
90 85
80

70 65
60

50
Min

40
30
30
20 20
20
10
10

0
Sifting Mixing Lubrication
8025 8026
Average wt.
100.45
100.4
100.4

100.35

100.3
(mg)

100.25
100.2
100.2

100.15

100.1

100.05
1 2

Uniformity of content
120.00%
109.90%
104.10%
100.00% 96.80%
84.10%
80.00%

60.00%

40.00%

20.00%

0.00%
Min Max

8025 8026
Thickness
3.02
3
3

2.98

2.96
mm

2.94
2.92
2.92

2.9

2.88
1 2

Diameter
6.7 6.69

6.68

6.66

6.64
mm

6.62 6.61

6.6

6.58

6.56
1 2
6.62 6.61

6.6

6.58

6.56
1 2

Dissolution
100.00%
97.60% 97.90%
98.00%

96.00%

94.00%
92.80%
(D)%

92.00%
90.10%
90.00%

88.00%

86.00%
1 2

Min Max

Assay
109.80% 109.70%
109.60%
109.40%
109.20%
109.00%
108.80% 108.70%
108.60%
108.40%
108.20%
108.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Atosta-20 Tablets

Manufacturing Time (min) Dissolution (D)%


Batch Average Thickness Diameter Assay
No: Sifting Mixing Lubrication Wt. (mg) (mm) (mm) Min Max (Atorvastatin)

8005 30 30 10 122.6 3.41 6.43 89.60% 103.60% 103.60%


Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acosart-25 Tablets

Manufacturing Time (min) Dissolution (D)% Assay


Batch Average Thickness Diameter
DT (Losartan
No: Sifting Mixing Lubrication Wt. (mg) (mm) (mm) Min Max Potassium)
8007 30 20 20 153.9 6 min 10 sec 3.75 7.2 105.40% 112.10% 107.30%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acosart-50 Tablets

Manufacturing Time (min) Dissolution (D)% Assay


Batch Average Thickness Diameter
DT (Losartan
No: Sifting Mixing Lubrication Wt. (mg) (mm) (mm) Min Max Potassium)
8035 45 30 10 149.1 7 min 08 secs 3.64 7.24 96.30% 110.60% 108.60%
8117 75 20 5 150.2 7 min 13 secs 3.3 7.06 107.60% 112.80% 101.50%

Manufacturing Time
80 75
70
60
50 45
40
30
30
20
20
10
10 5
0
Sifting Mixing Lubrication
8035 8117
Average Wt.
150.4
150.2
150.2
150
149.8
149.6
149.4
149.2 149.1
149
148.8
148.6
148.4
1 2

DT
3.7
3.64
3.6

3.5

3.4

3.3
3.3

3.2

3.1
1 2
Thickness
3.7
3.64

3.6

3.5

3.4

3.3
3.3

3.2

3.1
1 2

Diameter
7.3

7.25 7.24

7.2

7.15

7.1
7.06
7.05

6.95
1 2
Dissolution
115.00% 112.80%
110.60%
110.00% 107.60%

105.00%

100.00%
96.30%
95.00%

90.00%

85.00%
Min Max
8035 8117

Assay
110.00%
108.60%
108.00%

106.00%

104.00%

102.00% 101.50%

100.00%

98.00%

96.00%
1 2
102.00% 101.50%

100.00%

98.00%

96.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acosart-H Tablet

Manufacturing Time (min) Dissolution % (D) Assay


Average Thickness Diameter Uniformity of content (%w/w) Losartan Potassium Hydrochlorothiazide
Batch No: DT Losartan
Sifting Mixing Lubrication Wt. (mg) (mm) (mm) Hydrochlorothiazide
Min Max Min Max Min Max Potassium
8036 50 30 10 168.07 4 min 40 sec 3.28 8.25 91.5 103.1 89.1 96.1 98.5 102.1 103.70% 101.30%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Cutimom Cream (15g)

Mixing time(min)
Assay
Before Avg.wt.
Batch No: After addition pH (Momentasone
addition of (g)
of API Furoate)
API
8008 280 105 5.32 15.00 108.70%
8105 260 120 5.6 15.1 100.80%

Mixing Time
300 280
260
250

200
(min)

150
120
105
100

50

0
1 2

Before addition of API After addition of API

pH
5.65
5.6
5.6
5.55
5.5
5.45
5.4
5.35 5.32
5.3
5.25
5.2
5.15
1 2
5.3
5.25
5.2
5.15
1 2

Average Wt.
15.12
15.1
15.10
15.08
15.06
15.04
15.02
15.00
15.00
14.98
14.96
14.94
1 2

Assay
110.00%
108.70%
108.00%

106.00%

104.00%

102.00%
100.80%
100.00%

98.00%

96.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Fluact Cream (15g)

Mixing time(min)
Assay
Batch Before After Avg.wt.
pH (Fluticasone
No: addition of addition of (g)
Propionate)
API API
8045 150 110 4.86 15.30 102.00%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Terif Cream (15g)

Mixing time(min)
Assay
Before After Avg.wt.
Batch No: pH (Terbinafine
addition of addition of (g)
HCL)
API API
8020 175 160 5.25 15.08 100.00%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Allerfix Suspension (60 ml)

Mixing time (min)


Avg. fill Weight Assay
Batch No: Before After pH volume per ml (Fexofenadine
addition of addition of (ml) (g) HCL)
API API
8022 280 150 6.13 60.5 1.13 103.10%
8064 380 130 5.97 60.3 1.1 100.80%
8092 285 150 6 60.6 1.13 103.90%

Mixing Time
400 380

350
300 280 285

250
(min)

200
150 150
150 130

100
50
0
1 2 3

Before addition of API After addition of API

pH
6.15 6.13

6.1

6.05
6
6
5.97

5.95

5.9

5.85
1 2 3
Avg. fill volume
60.65
60.6
60.6
60.55
60.5
60.5
60.45
60.4
(ml)

60.35
60.3
60.3
60.25
60.2
60.15
60.1
1 2 3

Weight per ml
1.135
1.13 1.13
1.13
1.125
1.12
1.115
(g)

1.11
1.105
1.1
1.1
1.095
1.09
1.085
1 2 3

Assay
104.50%
103.90%
104.00%
103.50% 103.10%
103.00%
102.50%
102.00%
101.50%
101.00% 100.80%
100.50%
100.00%
99.50%
99.00%
1 2 3
102.50%
102.00%
101.50%
101.00% 100.80%
100.50%
100.00%
99.50%
99.00%
1 2 3
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Allerfix Suspension (100 ml)

Mixing time (min)


Avg. fill Weight Assay
Batch No: Before After pH volume per ml (Fexofenadine
addition of addition of (ml) (g) HCL)
API API
8109 170 120 6.6 101.5 1.086 98.50%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Dex Kof Syrup (100 ml)

Mixing time (min) Assay


Avg. fill Weight
Batch No: Before After pH volume per ml
addition of addition of (ml) (g) Dextromethorphan Phenylephrine Triprolidine
API API
8021 85 160 4.6 100.5 1.14 104.50% 102.40% 103.70%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Sucfate Suspension (200 ml)

Mixing time (min)


Avg. fill Weight
Before After Assay
Batch No: pH volume per ml
addition of addition of (Sucralfate)
(ml) (g)
API API
8028 325 240 5.21 200.3 1.12 105.20%
8029 250 210 5.34 200.7 1.12 107.50%
8056 330 90 5.48 201 1.12 104.90%
8085 360 90 5.5 200.9 1.12 99.40%
8086 300 160 5.51 201.6 1.12 98.60%
8088 320 180 5.39 200.7 1.12 98.80%
8089 295 200 5.76 201.8 1.12 101.20%

Mixing time
400
360
350 325 330 320
300 295
300
240 250
250
210
Min

200
200 180
160
150
90 90
100
50
0
1 2 3 4 5 6 7

Before addition of API After addition of API

pH
5.9
5.8 5.76
5.7
5.6
5.5 5.51
5.48
5.5
5.39
5.4 5.34
5.3
5.21
5.2
5.1
5
4.9
1 2 3 4 5 6 7
5.3
5.21
5.2
5.1
5
4.9
1 2 3 4 5 6 7

Avg. fill volume


202 201.8
201.6
201.5

201
201 200.9
200.7 200.7
ml

200.5
200.3

200

199.5
1 2 3 4 5 6 7

Weight per ml
1.2 1.12 1.12 1.12 1.12 1.12 1.12 1.12

0.8

0.6

0.4

0.2

0
1 2 3 4 5 6 7

Assay (Sucralfate)
110.00%

108.00% 107.50%

106.00% 105.20% 104.90%


104.00%

102.00% 101.20%

100.00% 99.40%
98.60% 98.80%
98.00%

96.00%

94.00%
1 2 3 4 5 6 7
104.00%

102.00% 101.20%

100.00% 99.40%
98.60% 98.80%
98.00%

96.00%

94.00%
1 2 3 4 5 6 7
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acolev Syrup (60ml)

Mixing time (min)


Avg. fill Weight
Before After Assay (Levocitrizine
Batch No: pH volume per ml
addition addition Dihydrochloride)
(ml) (g)
of API of API
8083 60 100 5.04 61.5 1.12 106.70%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acotus Syrup (60ml)

Mixing time (min) Assay


Avg. fill Weight
Batch No: Before After pH volume per ml Bromhexine Terbutaline
addition of addition of (ml) (g) HCL Sulphate
API API
8099 100 90 3.87 61.2 1.06 100.80% 104.30%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acotus Syrup (100ml)

Mixing time (min) Assay


Avg. fill Weight
Batch No: Before After pH volume per ml Bromhexine Terbutaline
addition of addition of (ml) (g) HCL Sulphate
API API
8103 60 60 3.93 100.1 1.05 102.60% 101.80%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acotus XT Syrup

Mixing time (min) Assay


Avg. fill Weight
Batch No: Before After pH volume per ml Bromhexine Terbutaline
addition addition (ml) (g) HCL Sulphate
of API of API
8104 90 50 3.89 100.7 1.09 102.90% 105.10%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Topiket Cream (15g)

Mixing time(min)
Before After Avg.wt. Assay
Batch No: pH
addition of addition of (g) (Ketoconazole)
API API
8042 235 135 7.25 15.04 103.90%
8107 120 80 7.17 15 104.10%

Mixing Time
250 235

200

150 135
120
(min)

100 80

50

0
1 2

Before addition of API After addition of API

pH
7.26 7.25

7.24

7.22

7.2

7.18 7.17

7.16

7.14

7.12
1 2
Avg wt.
15.05
15.04
15.04

15.03

15.02

15.01
15
15.00

14.99

14.98
1 2

Assay
104.15%
104.10%
104.10%

104.05%

104.00%

103.95%
103.90%
103.90%

103.85%

103.80%

103.75%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Aclear Gel (15g)

Mixing time(min)
Batch Before After Avg.wt. Assay
pH
No: addition of addition of (g) (Adapalene)
API API
8034 180 95 4.85 15.10 104.00%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acoplex Syrup (200ml)

Mixing time (min) Assay


Avg. fill Weight
Batch No. Before After pH volume per ml Thiamine Pyridoxine
addition of addition of (ml) (g) Riboflavin Nicotinamide
Hydrochloride Hydrochloride
API API

8048 240 380 4.85 202.9 1.2 146.70% 143.00% 135.60% 127.20%
8049 150 390 4.88 202.5 1.2 148.20% 141.20% 134.00% 127.90%

Mixing time
450
400 380 390

350
300
250 240
Min

200
150
150
100
50
0
1 2

Before addition of API After addition of API


pH
4.885
4.88
4.88
4.875
4.87
4.865
4.86
4.855
4.85
4.85
4.845
4.84
4.835
4.83
1 2

Avg. fill volume


203
202.9
202.9

202.8

202.7
ml

202.6
202.5
202.5

202.4

202.3
1 2
202.6
202.5
202.5

202.4

202.3
1 2

Weight per ml
1.4
1.2 1.2
1.2

0.8
\

0.6

0.4

0.2

0
1 2

Axis Title

Assay
148.20%
150.00%
146.70%
141.20%
145.00% 143.00%
134.00%
140.00%
135.60% 127.90%
135.00%

130.00% 127.20%
125.00%

120.00%

115.00%
Thiamine Hydrochloride Riboflavin Pyridoxine Hydrochloride Nicotinamide
8048 8049
130.00% 127.20%
125.00%

120.00%

115.00%
Thiamine Hydrochloride Riboflavin Pyridoxine Hydrochloride Nicotinamide
8048 8049
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Clara Syrup (60 ml)

Mixing time (min)


Avg. fill
Before After Weight per Assay
Batch No: pH volume
addition of addition of ml (g) (Loratadine)
(ml)
API API
8027 50 110 2.86 60.5 1.11 104.70%
8098 240 120 2.59 61.5 1.11 98.60%

Mixing Time
300

250 240

200

150
110 120
100
50
50

0
1 2

Before addition of API After addition of API

pH
2.9
2.86
2.85
2.8
2.75
2.7
2.65
2.59
2.6
2.55
2.5
2.45
1 2
Avg. fill volume
61.6 61.5
61.4

61.2

61

60.8

60.6 60.5
60.4

60.2

60
1 2

Weight per ml
1.2 1.11 1.11

0.8

0.6

0.4

0.2

0
1 2

Assay
106.00%
104.70%
104.00%

102.00%

100.00%
98.60%
98.00%

96.00%

94.00%
1 2
100.00%
98.60%
98.00%

96.00%

94.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Ecoxib 90 Tablets

Manufacturing Time (min) Dissolution (D)%


Batch Preparation Average Thickness Diameter Assay
No: Sifting Mixing of Binder Granulation Lubrication Wt. (mg) (mm) (mm) Min Max (Etoricoxib)
Solution
8050 65 30 90 10 10 231 3.91 8.24 88.70% 89.80% 102.00%
8069 120 30 160 10 15 227.6 3.89 8.24 85.40% 89.90% 99.10%

Manufacturing Time
180
160
160
140
120
120
100 90
Min

80 65
60
40 30 30
20 10 10 10 15
0
Sifting Mixing Preparation of Granulation Lubrication
Binder Solution
8050 8069
Average Wt.
232
231
231

230

229
(mg)

228 227.6

227

226

225
1 2

Thickness
3.915
3.91
3.91

3.905

3.9
(mm)

3.895
3.89
3.89

3.885

3.88
1 2
9
Diameter
8.24 8.24
8
7
6
5
(mm)

4
3
2
1
0
1 2

Dissolution
91.00%
89.80% 89.90%
90.00%
89.00% 88.70%
(D)%

88.00%
87.00%
86.00% 85.40%
85.00%
84.00%
83.00%
Min Max
8050 8069
84.00%
83.00%
Min Max
8050 8069

Assay
102.50%
102.00%
102.00%
101.50%
101.00%
100.50%
100.00%
99.50% 99.10%
99.00%
98.50%
98.00%
97.50%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Ecoxib 60 Tablets

Manufacturing Time (min) Dissolution (D)%


Batch Preparation Average Thickness Diameter Assay
No: Sifting Mixing of Binder Granulation Lubrication Wt. (mg) (mm) (mm) Min Max (Etoricoxib)
Solution
8073 40 20 60 15 15 228.9 3.89 8.25 90.50% 95.40% 98.50%
8108 80 30 90 5 5 230.2 3.73 8.24 97.40% 109.40% 104.30%

Manufacturing Time
100 90
80
80
60
60
40
(min)

40 30
20
20 15 15
5 5
0
Sifting Mixing Preparation of Granulation Lubrication
Binder Solution

Axis Title

8073 8108
Average Weight
230.4
230.2
230.2
230
229.8
229.6
229.4
229.2
229 228.9
228.8
228.6
228.4
228.2
1 2

Thickness
3.95

3.9 3.89

3.85

3.8

3.75 3.73

3.7

3.65
1 2
3.75 3.73

3.7

3.65
1 2

Diameter
8.252
8.25
8.25
8.248
8.246
8.244
8.242
8.24
8.24
8.238
8.236
8.234
1 2

Dissolution
120.00% 109.40%
97.40% 95.40%
100.00% 90.50%

80.00%

60.00%

40.00%

20.00%

0.00%
Min Max

8073 8108
20.00%

0.00%
Min Max

8073 8108

Assay
105.00% 104.30%
104.00%
103.00%
102.00%
101.00%
100.00%
99.00% 98.50%
98.00%
97.00%
96.00%
95.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Ecoxib 120 Tablets

Manufacturing Time (min) Dissolution (D)%


Batch Preparation Average Thickness Diameter Assay
No: Sifting Mixing of Binder Granulation Lubrication Wt. (mg) (mm) (mm) Min Max (Etoricoxib)
Solution

8074 25 30 70 15 15 228.5 4.09 8.26 81.30% 86.00% 102.70%


8110 90 15 60 10 10 228 3.88 8.14 92.00% 94.90% 101.10%

Manufacturing Time
100 90
90
80 70
70 60
60
50
40 30
30 25
20 15 15 15
10 10
10
0
Sifting Mixing Preparation of Granulation Lubrication
Binder Solution
8074 8110
Average Wt.
228.6
228.5
228.5
228.4
228.3
228.2
228.1
228
228
227.9
227.8
227.7
1 2

Thickness
4.15

4.1 4.09

4.05

3.95

3.9 3.88

3.85

3.8

3.75
1 2
Diameter
8.28
8.26
8.26
8.24
8.22
8.2
8.18
8.16
8.14
8.14
8.12
8.1
8.08
1 2

Dissolution
100.00%
94.90%
95.00%
92.00%
90.00%
86.00%
85.00%
81.30%
80.00%

75.00%

70.00%
Min Max

8074 8110
80.00%

75.00%

70.00%
Min Max

8074 8110

Assay
103.00%
102.70%

102.50%

102.00%

101.50%
101.10%
101.00%

100.50%

100.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Looptor-5 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)%


Batch Average Thickness Diameter Assay
No: Sifting Mixing Granulation Lubrication Wt. (mg) Min Max (mm) (mm) Min Max (Torsemide)

8051 35 20 10 10 101.03 92.10% 104.90% 2.97 6.43 88.30% 92.80% 100.10%


8053 45 20 10 10 102.6 92.70% 102.30% 2.98 6.43 103.10% 107.70% 108.00%

Manufacturing Time
50
45
45
40
35
35
30
25
Min

20 20
20
15
10 10 10 10
10
5
0
Sifting Mixing Granulation Lubrication
8051 8053
Average Wt.
103
102.6
102.5

102

101.5
mg

101.03
101

100.5

100
1 2

Uniformity of Content
110.00%

104.90%
105.00%
102.30%

100.00%

95.00%
92.10% 92.70%

90.00%

85.00%
Min Max
8051 8053
90.00%

85.00%
Min Max
8051 8053

Thickness
2.982
2.98
2.98

2.978

2.976

2.974
(mm)

2.972
2.97
2.97

2.968

2.966

2.964
1 2

Diameter
7
6.43 6.43

4
(mm)

0
1 2
2

0
1 2

Dissolution
120.00%
107.70%
103.10%
100.00% 92.80%
88.30%

80.00%
(D)%

60.00%

40.00%

20.00%

0.00%
Min Max
8051 8053

Assay
110.00%
108.00%
108.00%

106.00%

104.00%

102.00%
100.10%
100.00%

98.00%

96.00%
1 2
102.00%
100.10%
100.00%

98.00%

96.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Looptor-10 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)%


Average Wt. Thickness Diameter Assay
Batch No:
Sifting Mixing Granulation Lubrication (mg) Min Max (mm) (mm) Min Max (Torsemide)

8046 20 20 10 10 107.7 97.50% 103.40% 3.1 6.45 101.40% 116.60% 107.10%


8054 55 20 10 10 107.2 97.30% 102.20% 3.1 6.45 100.30% 107.50% 108.20%

Manufacturing Time
60
55

50

40
(Min)

30

20 20 20
20

10 10 10 10
10

0
Sifting Mixing Granulation Lubrication
8046 8054
Average Wt.
107.8
107.7
107.7

107.6

107.5

107.4
(mg)

107.3
107.2
107.2

107.1

107

106.9
1 2

Uniformity of content
104.00% 103.40%
103.00%
102.20%
102.00%
101.00%
100.00%
99.00%
98.00% 97.50% 97.30%
97.00%
96.00%
95.00%
94.00%
Min Max

8046 8054
Thickness
3.5
3.1 3.1
3

2.5

2
(mm)

1.5

0.5

0
1 2

Diameter
7
6.45 6.45

4
(mm)

0
1 2
5

(mm)
3

0
1 2

Dissolution
120.00%
116.60%
115.00%

110.00%
107.50%

105.00%
101.40%
100.30%
100.00%

95.00%

90.00%
Min Max
8046 8054

Assay
108.40%
108.20%
108.20%

108.00%

107.80%

107.60%

107.40%

107.20% 107.10%
107.00%

106.80%

106.60%

106.40%
1 2
108.00%

107.80%

107.60%

107.40%

107.20% 107.10%
107.00%

106.80%

106.60%

106.40%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Looptor-20 Tablets

Manufacturing Time (min) Dissolution (D)%


Batch Average Thickness Diameter Assay
No: Sifting Mixing Granulation Lubrication Wt. (mg) (mm) (mm) Min Max (Torsemide)

8052 90 20 10 10 170.4 3.96 7.23 94.20% 101.40% 102.60%


8055 75 20 10 10 173.3 4.03 7.29 95.50% 107.60% 104.90%

Manufacturing Time
100
90
90
80 75
70
60
(min)

50
40
30
20 20
20
10 10 10 10
10
0
Sifting Mixing Granulation Lubrication
8052 8055
Average wt.
174
173.3
173

172
(mm)

171
170.4

170

169

168
1 2

Thickness
4.04 4.03

4.02

4
(mm)

3.98
3.96
3.96

3.94

3.92
1 2
3.96

3.94

3.92
1 2

Diameter
7.3
7.29
7.29
7.28
7.27
7.26
(mm)

7.25
7.24
7.23
7.23
7.22
7.21
7.2
1 2

Dissolution
110.00%
107.60%

105.00%
101.40%
100.00%
95.50%
95.00% 94.20%

90.00%

85.00%
Min Max
8052 8055
90.00%

85.00%
Min Max
8052 8055

Assay
105.50%
104.90%
105.00%
104.50%
104.00%
103.50%
103.00%
102.60%
102.50%
102.00%
101.50%
101.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Rosva 5 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)%


Batch Average Thickness Diameter Assay
No: Sifting Mixing Granulation Lubrication Wt. (mg) Min Max (mm) (mm) Min Max (Rosuvastatin)

8112 45 20 15 55 117.6 95.10% 109.80% 3.18 6.43 87.00% 96.80% 103.90%


Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Rosva 10 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)%


Batch Average Thickness Diameter Assay
No: Sifting Mixing Granulation Lubrication Wt. (mg) Min Max (mm) (mm) Min Max (Rosuvastatin)

8113 45 25 30 15 130.2 97.70% 101.30% 3.53 6.44 93.60% 98.70% 104.50%


Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Rosva 20 Tablets

Manufacturing Time (min) Dissolution (D)%


Batch Average Thickness Diameter Assay
No: Sifting Mixing Granulation Lubrication Wt. (mg) (mm) (mm) Min Max (Rosuvastatin)

8114 35 20 5 5 172.9 4.2 7.21 100.60% 104.90% 104.00%


Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Sitavia-50 Tablets

Manufacturing Time (min)


Batch Preparation of Average Thickness Diameter Assay
No: Sifting Mixing Binder Granulation Lubrication Wt. (mg) (mm) (mm) (Sitagliptin)
Solution
8093 25 20 35 40 5 173 7.22 3.79 100.70%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Sitavia-100 Tablets

Manufacturing Time (min)


Batch Preparation Average Thickness Diameter Assay
No: Sifting Mixing of Binder Granulation Drying Lubrication Wt. (mg) (mm) (mm) (Sitagliptin)
Solution
8094 35 20 60 60 90 5 271.3 3.96 9.03 99.00%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name:Acomet Suspension (60ml)

Mixing time (min)


Avg. fill Weight Assay
Batch Before After pH volume per ml (Metronidazole
No: addition of addition of (ml) (g) Benzoate )
API API
8060 240 90 5.56 60.5 1.03 107.50%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acomet-DF Suspension (60ml)

Mixing time (min) Assay


Avg. fill Weight
Batch No: Before After pH volume per ml Metronidazole Diloxanide
addition of addition of (ml) (g) Benzoate Furoate
API API
8061 390 80 5.81 61.8 1.02 107.00% 107.50%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Glotin-0.025 Gel (15g)

Mixing time(min)
Batch Before After Avg.wt. Assay
pH
No: addition of addition of (g) (Tretinoin)
API API
8065 120 80 6.19 15.02 129.60%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Glotin-0.05 Gel (15g)

Mixing time(min)
Batch Before After Avg.wt. Assay
pH
No: addition of addition of (g) (Tretinoin)
API API
8066 190 75 5.7 15.05 129.70%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Rumonac Gel (30g)

Mixing Time(min) Assay


Before After Avg.wt.
Batch No: pH Diclofenac Methyl
addition of addition of (g)
Diethylamine Salicylate
API API
8058 210 150 7.05 30.05 105.10% 104.60%
8059 540 75 6.86 30.12 104.50% 105.80%

Mixing Time
600
540
500

400

300
Min

210
200 150

100 75

0
1 2

Before addition of API After addition of API

pH
7.1
7.05
7.05

6.95

6.9
6.86
6.85

6.8

6.75
1 2
Avg.wt.
30.14
30.12
30.12

30.10

30.08
g

30.06 30.05

30.04

30.02

30.00
1 2

Assay
106.00% 105.80%

105.50%
105.10%
105.00%
104.60%
104.50%
104.50%

104.00%

103.50%
1 2

Diclofenac Diethylamine Methyl Salicylate


Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acloba Cream (15g)

Mixing time(min)
Assay
Batch Before After Avg.wt.
pH (Clobetasol
No: addition of addition of (g)
Propionate)
API API
8081 170 145 5.62 15.19 102.20%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acloba-G Cream (15g)

Mixing Time(min) Assay


Batch Before After Avg.wt.
pH Clobetasol
No: addition of addition of (g) Gentamicin
Propionate
API API
8062 170 135 4.85 15.09 100.50% 102.45%
8123 210 120 5.07 15.33 106.60% 104%

Mixing Time
250
210
200
170

150 135
120

100

50

0
1 2

Before addition of API After addition of API

pH
5.1 5.07
5.05

4.95

4.9
4.85
4.85

4.8

4.75

4.7
1 2
Avg.wt.
15.35 15.33

15.30

15.25

15.20

15.15

15.10 15.09

15.05

15.00

14.95
1 2

Assay
108.00%
106.60%
106.00%
104%
104.00%
102.45%
102.00%
100.50%
100.00%

98.00%

96.00%
1 2

Clobetasol Propionate Gentamicin


Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acloba-GM Cream (15g)

Mixing Time(min) Assay


Batch No: Before After pH Avg.wt. (g) Clobetasol
addition of addition of Gentamicin Miconazole Nitrate
Propionate
API API
8063 145 150 4.87 15.26 104.10% 102.66% 98.90%
8124 170 135 5.32 15.41 108.60% 100.80% 102.90%

Mixing Time
180 170
160 145 150
140 135

120
100
80
60
40
20
0
1 2

Before addition of API After addition of API


pH
5.4
5.32
5.3

5.2

5.1

4.9 4.87

4.8

4.7

4.6
1 2

Avg.wt.
15.45

15.40

15.35

15.30

15.25

15.20

15.15
1 2
15.25

15.20

15.15
1 2

Assay
110.00% 108.60%
108.00%
106.00%
104.10%
104.00% 102.66% 102.90%
102.00% 100.80%
100.00% 98.90%
98.00%
96.00%
94.00%
Clobetasol Propionate Gentamicin Miconazole Nitrate
8063 8124
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Halotop Cream (15g)

Mixing time(min)
Assay
Batch Before After Avg.wt.
pH (Halobetasol
No: addition of addition of (g)
Propionate)
API API
8067 160 90 6.24 15.09 103.50%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Halotop-G Cream (15g)

Mixing time(min) Assay


Batch Before After Avg.wt.
pH Halobetasol
No: addition of addition of (g) Gentamicin
Propionate
API API
8068 160 140 5.36 15.04 107.00% 100.37%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Prozin Syrup (60ml)

Mixing time (min)


Avg. fill Weight Assay
Batch No: Before After pH volume per ml (Promethazine
addition of addition of (ml) (g) HCL )
API API
8070 210 80 4.9 60.7 1.1 104.10%
8101 150 205 5.04 60.1 1.1 104.20%

Mixing Time
250
210 205
200

150
150
(min)

100 80

50

0
1 2

Before addition of API After addition of API

pH
5.1

5.05 5.04

4.95
4.9
4.9

4.85

4.8
1 2
Avg. fill volume
60.8
60.7

60.6

60.4

60.2
(ml)

60.1

60

59.8

59.6
1 2

Weight per ml
1.2
1.1 1.1

0.8

0.6

0.4

0.2

0
1 2

Assay
104.22%
104.20%
104.20%
104.18%
104.16%
104.14%
104.12%
104.10%
104.10%
104.08%
104.06%
104.04%
1 2
104.12%
104.10%
104.10%
104.08%
104.06%
104.04%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Lijenta 2.5 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)%


Average Wt. Thickness Diameter Assay
Batch No:
Sifting Mixing Granulation Lubrication (mg) Min Max (mm) (mm) Min Max (Linagliptin)

8084 40 20 30 20 114.7 95.50% 106.80% 3.34 6.48 104.90% 115.60% 104.90%


8125 60 30 20 30 112.8 90.60% 93.50% 3.18 6.47 90.60% 96.00% 100.20%

Manufacturing Time
70

60
60

50

40
40

30 30 30
30

20 20 20
20

10

0
Sifting Mixing Granulation Lubrication

8084 8125
Average Wt.
115
114.7

114.5

114

113.5

113 112.8

112.5

112

111.5
1 2

Uniformity of content
110.00%
106.80%

105.00%

100.00%

95.50%
95.00% 93.50%
90.60%
90.00%

85.00%

80.00%
Min Max

8084 8125
Thickness
3.4

3.35 3.34

3.3

3.25

3.2 3.18

3.15

3.1
1 2

Diameter
6.482
6.48
6.48

6.478

6.476

6.474

6.472
6.47
6.47

6.468

6.466

6.464
1 2
6.468

6.466

6.464
1 2

Dissolution
140.00%

120.00% 115.60%
104.90%
100.00% 96.00%
90.60%

80.00%

60.00%

40.00%

20.00%

0.00%
Min Max
8084 8125

Assay
106.00%
104.90%
105.00%

104.00%

103.00%

102.00%

101.00%
100.20%
100.00%

99.00%

98.00%

97.00%
1 2
100.00%

99.00%

98.00%

97.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Lijenta 5 Tablets

Manufacturing Time (min) Uniformity of content(%) Dissolution (D)%


Average Thickness Diameter Assay
Batch No: Roll
Sifting Mixing Lubrication Wt. (mg) Min Max (mm) (mm) Min Max (Linagliptin)
Compaction

8082 30 20 30 10 112 113.40% 114.70% 3.2 6.43 107.20% 111.50% 99.00%


8126 55 25 100 5 114.8 103.90% 108.80% 3.21 6.43 101.00% 106.00% 103.30%

Manufacturing Time
120

100
100

80

60 55

40
30 30
25
20
20
10
5
0
Sifting Mixing Roll Compaction Lubrication
8082 8126
Average Wt.
115.5

115 114.8

114.5

114

113.5

113

112.5
112
112

111.5

111

110.5
1 2

Uniformity of content
116.00% 114.70%
114.00% 113.40%

112.00%
110.00% 108.80%
108.00%
106.00%
103.90%
104.00%
102.00%
100.00%
98.00%
Min Max

8082 8126
100.00%
98.00%
Min Max

8082 8126

Thickness
3.212
3.21
3.21

3.208

3.206

3.204

3.202
3.2
3.2

3.198

3.196

3.194
1 2

Diameter
7
6.43 6.43

0
1 2
2

0
1 2

Dissolution
114.00%
112.00% 111.50%

110.00%
108.00% 107.20%
106.00%
106.00%
104.00%
102.00% 101.00%
100.00%
98.00%
96.00%
94.00%
Min Max

8082 8126

Assay
104.00%
103.30%
103.00%

102.00%

101.00%

100.00%
99.00%
99.00%

98.00%

97.00%

96.00%
1 2
99.00%
99.00%

98.00%

97.00%

96.00%
1 2
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acovit C Tablets

Manufacturing Time (min) Assay


Average Friability Thickness Diameter
Batch No: Hardness (Ascorbic
Sifting Mixing Granulation Lubrication Wt. (mg) (%w/w) (mm) (mm)
Acid)
8090 110 35 60 20 794.9 0.08 14 4.27 12.8 98.40%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Acolev Tablets

Manufacturing Time (min) Uniformity of Content Dissolution % (D) Assay


Batch Average Thickness
Hardness Diameter (mm) (Levocitrizine
No: Sifting Mixing Granulation Lubrication Wt. (mg) Min Max (mm) Min Max (2HCl )
8087 30 20 15 10 103.2 97.40% 101.40% 8.2 2.99 6.46 95.60% 98.50% 101.80%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Clotrim Cream (15g)

Mixing time(min)
Batch Before After Avg.wt. Assay
pH
No: addition of addition of (g) (Clotrimazole)
API API
8111 240 120 5.98 15.10 102.30%
Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Zoom-250 Tablets

Manufacturing Time (min) Dissolution % (D)


Batch Average Thickness Diameter Assay
No: Prepration of Wt. (mg) (mm) (mm) (Azithromycin)
Sifting binder Granulation Drying Lubrication Min Max
solution

8121 50 90 20 120 15 402.1 4.79 11.29 99.50% 115.10% 102.50%


Annual Product Review (APR)
(F.Y. 78/79)
Product Name: Zoom-500 Tablets

Manufacturing Time (min) Dissolution % (D)


Batch Prepration Average Thickness Length Assay
No: Sifting of binder Granulation Drying Lubrication Wt. (mg) (mm) (mm) Min Max (Azithromycin)
solution
8122 180 50 20 60 25 725.7 5.38 18.2 84.50% 102.20% 102.20%

You might also like